Pharmacology at University of Manchester - UCAS

Course options

There are other course options available which may have a different vacancy status or entry requirements – view the full list of options

Course summary

Our PhD/MPhil Pharmacology programme enables you to undertake a research project that will improve understanding of Pharmacology. Our pharmacology research focuses on a range of topics. These include:

  • The pharmacology of drug efflux transporters, particularly ABCB1 P-glycoprotein, ABCG2 breast cancer resistance protein and ABCC multidrug resistance-associated transporters;
  • Developing complex, physiologically-relevant in vitro cell systems to investigate transport, metabolism and delivery of therapeutic drugs;
  • Understanding the pharmacological and molecular mechanisms that regulate expression and function of drug efflux transporters, particularly in the blood-brain barrier;
  • The role of blood-brain barrier drug efflux transporters in drug delivery to the central nervous system and the effects of inflammatory and degenerative conditions, e.g. Alzheimer's disease, on efflux transporter function;
  • The biological role of lipid networks in health and disease, particularly their roles in inflammation, cellular communications and tissue responses;
  • Employing mass spectrometry-based lipidomic technology, in conjunction with functional, metabolic and signalling approaches to characterise lipid profiles in physiological and pathophysiological conditions;
  • Investigating the role of lipids in skin homeostasis and in response to inflammation, injury and wound healing;
  • Studying role of local hormones in diseases and conditions associated with the female reproductive tract (e.g. dysmenorrhoea, endometriosis and the detection and prevention of preterm labour);
  • Molecularly identifying and pharmacologically characterising receptors expressed in the female reproductive system;
  • Understanding the physiological and pharmacological characteristics of the placenta. These studies include the development of placental homing peptide-microRNA inhibitor conjugates for targeted enhancement of placental growth signalling.


How to apply

International applicants

This course has a subject classification which requires students whose nationality is outside the European Economic Area (EEA) or Switzerland to have an ATAS certificate, irrespective of country of residence at the point of application.

Further information can be found on the UK Government's website: www.gov.uk/academic-technology-approval-scheme

Entry requirements

We require applicants to hold, or be about to obtain, an Upper Second class Honours degree (or overseas equivalent) in a related subject area for entry to a PhD programme. A Lower Second class Honours degree may be considered if applicants also hold a Master's degree with a Merit classification.


Fees and funding

Tuition fees

No fee information has been provided for this course

Additional fee information

Fees for entry in 2023 have not yet been set.
Pharmacology at University of Manchester - UCAS